1. Finegold SM. Anaerobic infections in humans: an overview. Anaerobe 1995; 1: 3-9.
2. Sutter VL, Finegold SM. Anaerobic bacteria: their recognition and significance in the clinical laboratory. Prog Clin Pathol 1973; 5: 219-238.
3. Noor A, Khetarpal S. Anaerobic Infections. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
4. Munson E, Carella A, Carroll KC. Valid and accepted novel bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2022. J Clin Microbiol 2023; 61:
e0083823.
5. Finegold SM. A century of anaerobes: a look backward and a call to arms. Clin Infect Dis 1993; 16 Suppl 4: S453-457.
6. Martin WF, Sousa FL. Early microbial evolution: The age of anaerobes. Cold Spring Harb Perspect Biol 2015; 8: a018127.
7. Hanišáková N, Vítězová M, Rittmann SKR. The historical development of cultivation techniques for methanogens and other strict anaerobes and their application in modern microbiology.
Microorganisms 2022; 10: 412.
8. Finegold SM. Mechanisms of resistance in anaerobes and new developments in testing. Diagn Microbiol Infect Dis 1989; 12(4 Suppl): 117S-120S.
9. Cornick NA, Cuchural GJ Jr, Snydman DR, et al. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. J Antimicrob Chemother 1990; 25: 1011-
1019.
10. Oren A, Arahal DR, Göker M, Moore ERB, Rossello-Mora R, Sutcliffe IC. International code of nomenclature of prokaryotes. Prokaryotic code (2022 Revision). Int J Syst Evol Microbiol 2023;
73(5a).
11. Kim M. Update on the taxonomy of clinically important anaerobic bacteria. Korean J Clin Lab Sci 2022; 54: 239-248.
12. Burbick CR, Lawhon SD, Bukouras B, Lazzerini G, Munson E. An update on novel taxa and revised taxonomic status of bacteria isolated from aquatic host species described in 2022-2023. J
Clin Microbiol 2024; 62: e0104324.
13. Engelkirk PG, Engelkirk JD, Dowell VR. Principles and practice of clinical anaerobic bacteriology. Blmont: Star; 1992.
14. Ślesak I, Kula M, Ślesak H, Miszalski Z, Strzałka K. How to define obligatory anaerobiosis? An evolutionary view on the antioxidant response system and the early stages of the evolution of
life on Earth. Free Radic Biol Med 2019; 140: 61-73.
15. Brioukhanov AL, Netrusov AI. Catalase and superoxide dismutase: distribution, properties, and physiological role in cells of strict anaerobes. Biochemistry (Mosc) 2004; 69: 949-962.
16. Andrade JC, Almeida D, Domingos M, et al. Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies. Front Bioeng Biotechnol 2020; 8: 550.
17. Hiippala K, Jouhten H, Ronkainen A, et al. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 2018; 10: 988.
18. Boattini M, Bianco G, Bastos P, et al. Diagnostic and epidemiological landscape of anaerobic bacteria in Europe, 2020-2023 (ANAEuROBE). Int J Antimicrob Agents 2025; 65:107478.
19. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infections Research. Chapter 1-1. Anaerobic infections
(General): epidemiology of anaerobic infections. J Infect Chemother 2011; 17 Suppl 1: 4-12.
20. Singh C, Sood A, Bala K, Tandup C, Ray P, Angrup A. Anaerobic infections in patients admitted in various surgical units of a tertiary care hospital of north India: neglected but important.
Iran J Microbiol 2021; 13: 274-281.
21. Hofstad T. Virulence factors in anaerobic bacteria. Eur J Clin Microbiol Infect Dis 1992; 11: 1044-1048.
22. Boquet P, Munro P, Fiorentini C, Just I. Toxins from anaerobic bacteria: specificity and molecular mechanisms of action. Curr Opin Microbiol 1998; 1: 66-74.
23. Popoff MR, Bouvet P. Clostridial toxins. Future Microbiol 2009; 4: 1021-1064.
24. Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev 2009; 22: 349-369.
25. Yekani M, Baghi HB, Naghili B, Vahed SZ, Sóki J, Memar MY. To resist and persist: Important factors in the pathogenesis of Bacteroides fragilis. Microb Pathog 2020; 149: 104506.
26. Boyanova L, Boyanova L, Hadzhiyski P, Gergova R, Markovska R. Oxygen tolerance in anaerobes as a virulence factor and a health-beneficial property. Anaerobe 2024; 89: 102897.
27. Mortensen KK, Nielsen HL, Søgaard KK. Clinical and microbiological characteristics of anaerobic bacteremia during 1994-2019: A Danish population-based cohort study. Anaerobe 2024;
89: 102898.
28. Cobo F, Aliaga L, Expósito-Ruiz M, Navarro-Marí JM. Anaerobic bacteraemia: A score predicting mortality. Anaerobe 2020; 64: 102219.
29. Brook I. Overview of anaerobic infections in children and their treatment. J Infect Chemother 2024; 30: 1104-1113.
30. Kumar S. Evidence-Based Update on Diagnosis and Management of Gingivitis and Periodontitis. Dent Clin North Am 2019; 63: 69-81.
31. Mysak J, Podzimek S, Sommerova P, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res 2014; 2014: 476068.
32. Brook I. Current management of upper respiratory tract and head and neck infections. Eur Arch Otorhinolaryngol 2009; 266: 315-323.
33. Levison ME. Anaerobic pleuropulmonary infection. Curr Opin Infect Dis 2001; 14: 187-191.
34. Brook I. Microbiology and management of abdominal infections. Dig Dis Sci 2008; 53: 2585-2591.
35. Chen X, Lu Y, Chen T, Li R. Tthe female vaginal microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol 2021; 11: 631972.
36. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Chapter 2-8. Anaerobic infections
(individual fields): infections in the field of orthopedics (primarily bone and joint infections). J Infect Chemother 2011; 17 Suppl 1: 105-107.
37. Rimoldi SG, Brioschi D, Curreli D, et al. Traditional Cultures versus Next Generation Sequencing for Suspected Orthopedic Infection: Experience Gained from a Reference Centre. Antibiotics
(Basel) 2023; 12:1588.
38. Brook I. The role of anaerobic bacteria in cutaneous and soft tissue abscesses and infected cysts. Anaerobe 2007; 13: 171-177.
39. Santiago-Martínez MG, Ferry JG. Methods for Culturing Anaerobic Microorganisms. Methods Mol Biol 2023; 2648: 231-238.
40. Reissier S, Penven M, Guérin F, Cattoir V. Recent trends in antimicrobial resistance among anaerobic clinical isolates. Microorganisms 2023; 11: 1474.
41. Nagy E, Boyanova L, Justesen US; ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine labora-
tories. Clin Microbiol Infect 2018; 24:1139-1148.
42. Schuetz AN. Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis 2014; 59: 698-705.
43. Hartmeyer GN, Sóki J, Nagy E, Justesen US. Multidrug-resistant Bacteroides fragilis group on the rise in Europe? J Med Microbiol 2012; 61: 1784-1788.
44. García-Gubern CF, Colon-Rolon L, Bond MC. Essential concepts of wound management. Emerg Med Clin North Am 2010; 28: 951-967.
45. Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. Lancet Respir Med 2025; 13: 92-100.
46. Levy EI, Dinleyici M, Dinleyici E, Vandenplas Y. Clostridioides difficile Infections: Prevention and treatment strategies. Adv Exp Med Biol 2024; 1449: 175-186.
47. Lanzas C, Jara M, Tucker R, Curtis S; CDC Modeling Infectious Diseases in Healthcare Program (MinD). A review of epidemiological models of Clostridioides difficile transmission and
control (2009-2021). Anaerobe 2022; 74: 102541